Loading...
Please wait, while we are loading the content...
Similar Documents
About fACE: perioperative use of angiotensin-converting enzyme inhibitors.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Barodka, Viachaslau M. Nyhan, Daniel P. Berkowitz, Dan Ezra |
| Copyright Year | 2012 |
| Abstract | Since the introduction of the first Angiotensin-converting enzyme inhibitor (ACEI) captopril in 1981, ACE inhibitors have become a mainstay of anti-hypertensive therapy. In addition to lowering BP, there is overwhelming evidence that ACE inhibitors (and angiotensin-receptor blockers (ARB)) provide end organ protection independent of blood their pressure lowering properties in diseases such as CHF, post MI, diabetes, and renal insufficiency.1 It is an unresolved issue, however, if ACE inhibitors have a protective or deleterious effect on perioperative outcomes2. (SELECT FULL TEXT TO CONTINUE) |
| Starting Page | 1 |
| Ending Page | 8 |
| Page Count | 8 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/126/3/249.full.pdf?download=true |
| PubMed reference number | 22715474v1 |
| Alternate Webpage(s) | https://doi.org/10.1161/CIRCULATIONAHA.112.117671 |
| DOI | 10.1161/CIRCULATIONAHA.112.117671 |
| Journal | Circulation |
| Volume Number | 126 |
| Issue Number | 3 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Angiotensins Antihypertensive Agents Captopril Cardiomyopathies Diabetes Mellitus Heart failure Myocardial Infarction |
| Content Type | Text |
| Resource Type | Article |
